tesamorelin's Phase 3 evidence base remains HIV-lipodystrophy focused, with no large non-HIV obesity trials published 20242026 [12]
doi: 10.1056/NEJMoa2108269 62 Effect of Liraglutide on Body Weight in Non-Diabetic Obese Subjects or Overweight Subjects With Co-Morbidities: SCALE-Obesity and Pre-Diabetes (2011)
Morus alba : Sample pre-treatment influences the in vitro DPP-IV inhibitory activity Recent data has also reported Morus alba (also called white mulberry) as a potential DPP-IV inhibitor
Bodnar M, Konieczka P, Namiesnik J
* Correspondence: Takao Hirotsu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Results May Vary: Individual results will vary based on factors including age, baseline health condition, metabolic factors, consistency of use, genetic factors, current medications, dietary habits, physical activity levels, and other individual variables